Navitor Pharmaceuticals nabs $33M for drugs that treat aging-related disorders
Navitor Pharmaceuticals expects, with this new fund raise, to bring its small molecule drugs that treat aging-related issues to the clinic by 2018.
navitor pharmaceuticals